DK0678025T3 - Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform - Google Patents

Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform

Info

Publication number
DK0678025T3
DK0678025T3 DK94907804T DK94907804T DK0678025T3 DK 0678025 T3 DK0678025 T3 DK 0678025T3 DK 94907804 T DK94907804 T DK 94907804T DK 94907804 T DK94907804 T DK 94907804T DK 0678025 T3 DK0678025 T3 DK 0678025T3
Authority
DK
Denmark
Prior art keywords
camptothecin
insoluble
water
lactone ring
cancer
Prior art date
Application number
DK94907804T
Other languages
English (en)
Inventor
Beppino C Giovanella
Hellmuth R Hinz
Anthony J Kozielski
John S Stehlin
Original Assignee
Stehlin Foundation For Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stehlin Foundation For Cancer filed Critical Stehlin Foundation For Cancer
Application granted granted Critical
Publication of DK0678025T3 publication Critical patent/DK0678025T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK94907804T 1993-01-15 1994-01-14 Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform DK0678025T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US284493A 1993-01-15 1993-01-15
PCT/US1994/000403 WO1994015604A1 (en) 1993-01-15 1994-01-14 Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form

Publications (1)

Publication Number Publication Date
DK0678025T3 true DK0678025T3 (da) 1998-10-07

Family

ID=21702794

Family Applications (3)

Application Number Title Priority Date Filing Date
DK97101631T DK0778024T3 (da) 1993-01-15 1994-01-14 Oral eller intramuskulær behandling af pancreascancer med vanduopløselig S-camptothecin i lukket lactonring-formen
DK02015200T DK1250926T3 (da) 1993-01-15 1994-01-14 Anvendelse af vanduoplöseligt S-camptothecin med en lukket lactonring i fremstilling af et medikament til behandling af coloncancer
DK94907804T DK0678025T3 (da) 1993-01-15 1994-01-14 Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK97101631T DK0778024T3 (da) 1993-01-15 1994-01-14 Oral eller intramuskulær behandling af pancreascancer med vanduopløselig S-camptothecin i lukket lactonring-formen
DK02015200T DK1250926T3 (da) 1993-01-15 1994-01-14 Anvendelse af vanduoplöseligt S-camptothecin med en lukket lactonring i fremstilling af et medikament til behandling af coloncancer

Country Status (9)

Country Link
EP (3) EP1250926B1 (da)
JP (1) JP3099128B2 (da)
AT (3) ATE227573T1 (da)
CA (1) CA2148822C (da)
DE (3) DE69435084T2 (da)
DK (3) DK0778024T3 (da)
ES (3) ES2301590T3 (da)
PT (1) PT1250926E (da)
WO (1) WO1994015604A1 (da)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244903A (en) * 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
ATE211142T1 (de) * 1989-09-15 2002-01-15 Res Triangle Inst Verfahren zur herstellung von 10,11-methylendioxy-20(rs)-camptothecin und 10,11-methylendioxy-20(s)-camptothecin-analog
US5422344A (en) * 1990-05-08 1995-06-06 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method of treating retroviral infections in mammals
ATE136898T1 (de) * 1991-10-29 1996-05-15 Glaxo Wellcome Inc Wasserlösliche camptothecinderivate
EP1393730A3 (en) * 1991-11-15 2004-03-17 Smithkline Beecham Corporation Combination chemotherapy involving topotecan and a platinum coordination compound
CA2125293A1 (en) * 1991-12-10 1993-06-24 Randall Keith Johnson Treatment of colorectal cancer

Also Published As

Publication number Publication date
EP0678025A1 (en) 1995-10-25
DE69431731T2 (de) 2003-03-13
ATE165003T1 (de) 1998-05-15
EP0778024B1 (en) 2002-11-13
DE69431731D1 (de) 2002-12-19
WO1994015604A1 (en) 1994-07-21
ES2186812T3 (es) 2003-05-16
JPH08505626A (ja) 1996-06-18
EP1250926B1 (en) 2008-03-12
JP3099128B2 (ja) 2000-10-16
EP0778024A1 (en) 1997-06-11
DE69435084D1 (de) 2008-04-24
DK1250926T3 (da) 2008-07-07
PT1250926E (pt) 2008-06-11
DK0778024T3 (da) 2002-12-23
ES2301590T3 (es) 2008-07-01
CA2148822A1 (en) 1994-07-21
ATE227573T1 (de) 2002-11-15
EP0678025B1 (en) 1998-04-15
EP1250926A2 (en) 2002-10-23
DE69409633D1 (de) 1998-05-20
DE69435084T2 (de) 2009-03-19
ES2114681T3 (es) 1998-06-01
CA2148822C (en) 2001-03-27
DE69409633T2 (de) 1998-08-06
ATE388706T1 (de) 2008-03-15
EP1250926A3 (en) 2002-11-20

Similar Documents

Publication Publication Date Title
ATE352289T1 (de) Mittel zur oralen verabreichung
DK203787A (da) Praeparat til nasal administrering
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DE3856052D1 (de) Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus
HUP0204282A2 (hu) Biszszulfonamidok alkalmazása hiperlipidémia kezelésére vagy megelőzésére alkalmas gyógyászati készítmények előállítására
DK0678025T3 (da) Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform
DE69233773D1 (de) Verwendung von topotecan zur herstellung eines medikaments zur verwendung in der behandlung von ovarialkrebs
GB9202993D0 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
DK0490380T3 (da) Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
AU628492B2 (en) Improvements in chemical compounds
UA37934A (uk) Спосіб профілактики карієсу зубів